CENCORA INC (1COR.MI) Stock Price & Overview
BIT:1COR • US03073E1055
Current stock price
The current stock price of 1COR.MI is 268.1 EUR. Today 1COR.MI is down by -5.43%.
1COR.MI Key Statistics
- Market Cap
- 52.153B
- P/E
- 19.36
- Fwd P/E
- 15.93
- EPS (TTM)
- 13.85
- Dividend Yield
- 0.74%
1COR.MI Stock Performance
1COR.MI Stock Chart
1COR.MI Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to 1COR.MI.
1COR.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to 1COR.MI. 1COR.MI has only an average score on both its financial health and profitability.
1COR.MI Earnings
On February 4, 2026 1COR.MI reported an EPS of 4.08 and a revenue of 85.93B. The company beat EPS expectations (0.03% surprise) and missed revenue expectations (-1.1% surprise).
1COR.MI Forecast & Estimates
18 analysts have analysed 1COR.MI and the average price target is 335.52 EUR. This implies a price increase of 25.15% is expected in the next year compared to the current price of 268.1.
For the next year, analysts expect an EPS growth of 11.29% and a revenue growth 7.91% for 1COR.MI
1COR.MI Financial Highlights
Over the last trailing twelve months 1COR.MI reported a non-GAAP Earnings per Share(EPS) of 13.85. The EPS increased by 14.99% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 0.5% | ||
| ROA | 2.07% | ||
| ROE | 85.16% | ||
| Debt/Equity | 3.97 |
1COR.MI Ownership
1COR.MI Industry Overview
1COR.MI operates in the Health Care Distributors sub-industry within the Health Care sector. This group contains 7 stocks and is scored by ChartMill on both price strength and growth momentum.
Industry Growth Score
Relative Performance
Each rank shows how many other sub-industries were outperformed over that timeframe.
Industry Fundamentals & Breadth
- Members
- 7
- New Highs
- 14.3%
- New Lows
- 0%
- Average ROE
- 76.1%
- Average Profit Margin
- 0.9%
- Average Operating Margin
- 1.5%
- Average P/E
- 19.8
- Average Fwd P/E
- 16.8
- Average Debt/Equity
- 3.5
1COR.MI Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| AMP | AMPLIFON SPA | 14.18 | 2.128B | ||
| AXNA | AMPLIFON SPA | 13.6 | 2.041B | ||
| FAGR | FAGRON | 15.96 | 1.77B | ||
| UPR | UNIPHAR PLC | 16.2 | 1.08B | ||
| ILM1 | MEDIOS AG | 10.96 | 349.487M | ||
| BLC | BASTIDE LE CONFORT MEDICAL | 12.22 | 184.618M | ||
| VME | VIROMED MEDICAL AG | N/A |
Related stock screener links
View all stocks in the Health Care Distributors Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Milan Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About 1COR.MI
Company Profile
Cencora, Inc. is a pharmaceutical sourcing and distribution services company. The company is headquartered in Conshohocken, Pennsylvania and currently employs 51,000 full-time employees. The firm helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The firm operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.
Company Info
IPO: 1996-05-28
CENCORA INC
1 West First Avenue
Conshohocken PENNSYLVANIA US
Employees: 51000
Phone: 13026587581
CENCORA INC / 1COR.MI FAQ
What does 1COR do?
Cencora, Inc. is a pharmaceutical sourcing and distribution services company. The company is headquartered in Conshohocken, Pennsylvania and currently employs 51,000 full-time employees. The firm helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The firm operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.
What is the current price of 1COR stock?
The current stock price of 1COR.MI is 268.1 EUR. The price decreased by -5.43% in the last trading session.
Does CENCORA INC pay dividends?
CENCORA INC (1COR.MI) has a dividend yield of 0.74%. The yearly dividend amount is currently 1.91.
What is the ChartMill rating of CENCORA INC stock?
1COR.MI has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Where is CENCORA INC (1COR.MI) stock traded?
1COR.MI stock is listed on the Euronext Milan exchange.
Is CENCORA INC (1COR.MI) expected to grow?
The Revenue of CENCORA INC (1COR.MI) is expected to grow by 7.91% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.